154 related articles for article (PubMed ID: 33242753)
21. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Jung NY; Yoo IR; Kang BJ; Kim SH; Chae BJ; Seo YY
Breast Cancer; 2016 Jan; 23(1):141-148. PubMed ID: 24872087
[TBL] [Abstract][Full Text] [Related]
22. Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria.
Gruber R; Walter E; Helbich TH
Eur J Radiol; 2010 Jun; 74(3):519-24. PubMed ID: 19427153
[TBL] [Abstract][Full Text] [Related]
23. Breast ultrasound in 22,131 asymptomatic women with negative mammography.
Girardi V; Tonegutti M; Ciatto S; Bonetti F
Breast; 2013 Oct; 22(5):806-9. PubMed ID: 23558244
[TBL] [Abstract][Full Text] [Related]
24. Optimizing breast cancer follow-up: diagnostic value and costs of additional routine breast ultrasound.
Wojcinski S; Farrokh A; Hille U; Hirschauer E; Schmidt W; Hillemanns P; Degenhardt F
Ultrasound Med Biol; 2011 Feb; 37(2):198-206. PubMed ID: 21208726
[TBL] [Abstract][Full Text] [Related]
25. Breast Cancer Detected at Screening US: Survival Rates and Clinical-Pathologic and Imaging Factors Associated with Recurrence.
Kim SY; Han BK; Kim EK; Choi WJ; Choi Y; Kim HH; Moon WK
Radiology; 2017 Aug; 284(2):354-364. PubMed ID: 28387638
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
[TBL] [Abstract][Full Text] [Related]
27. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
28. Incremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer.
Candelaria RP; Huang ML; Adrada BE; Bassett R; Hunt KK; Kuerer HM; Smith BD; Chavez-MacGregor M; Yang WT
Acad Radiol; 2017 Feb; 24(2):191-199. PubMed ID: 27955877
[TBL] [Abstract][Full Text] [Related]
29. How reassuring is a normal breast ultrasound in assessment of a screen-detected mammographic abnormality? A review of interval cancers after assessment that included ultrasound evaluation.
Bennett ML; Welman CJ; Celliers LM
Clin Radiol; 2011 Oct; 66(10):928-39. PubMed ID: 21718976
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
[TBL] [Abstract][Full Text] [Related]
31. US surveillance of regional lymph node recurrence after breast cancer surgery.
Moon HJ; Kim MJ; Kim EK; Park BW; Youk JH; Kwak JY; Sohn J; Kim SI
Radiology; 2009 Sep; 252(3):673-81. PubMed ID: 19546429
[TBL] [Abstract][Full Text] [Related]
32. Surveillance of women with a personal history of breast cancer by tumour subtype.
Benveniste AP; Dryden MJ; Bedrosian I; Morrow PK; Bassett RL; Yang W
Clin Radiol; 2017 Mar; 72(3):266.e1-266.e6. PubMed ID: 28341031
[TBL] [Abstract][Full Text] [Related]
33. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
[TBL] [Abstract][Full Text] [Related]
34. Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.
de Ligt KM; Witteveen A; Siesling S; Steuten LMG
BMC Cancer; 2018 Jan; 18(1):96. PubMed ID: 29361911
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
36. Supplemental Breast US Screening in Women with a Personal History of Breast Cancer: A Matched Cohort Study.
Kim SY; Cho N; Kim SY; Choi Y; Kim ES; Ha SM; Lee SH; Chang JM; Moon WK
Radiology; 2020 Apr; 295(1):54-63. PubMed ID: 32096704
[TBL] [Abstract][Full Text] [Related]
37. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
Li Y; Arellano AR; Bare LA; Bender RA; Strom CM; Devlin JJ
Value Health; 2017 Apr; 20(4):547-555. PubMed ID: 28407996
[TBL] [Abstract][Full Text] [Related]
38. MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
Nadler M; Al-Attar H; Warner E; Martel AL; Balasingham S; Zhang L; Lipton JH; Curpen B
Breast; 2017 Aug; 34():77-82. PubMed ID: 28527397
[TBL] [Abstract][Full Text] [Related]
39. Necessity of Axillary Scanning After Negative Finding on Both Mammography and Subsequent Breast Ultrasound.
Youn I; Yoon JH; Youk JH; Moon HJ; Kim MJ; Kim EK; You JK
Ultrasound Med Biol; 2018 Jan; 44(1):71-77. PubMed ID: 29033094
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
